Lazard, Inc.

  • Market Cap: Small Cap
  • Industry: Capital Markets
  • ISIN: US52110M1099
USD
53.47
-0.01 (-0.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Lazard, Inc. stock-summary
stock-summary
Lazard, Inc.
Capital Markets
Lazard Ltd (Lazard) is a financial advisory and asset management company. The Company operates through two segments: Financial Advisory and Asset Management. It serves a range of clients around the world, including corporations, governments, institutions, partnerships and individuals. The Financial Advisory business segment offers corporate, partnership, institutional, government, sovereign and individual clients across the globe a range of financial advisory services regarding mergers and acquisitions (M&A) and other strategic matters, restructurings, capital structure, capital raising and various other financial matters to corporate, partnership, institutional, government, sovereign and individual clients. The Asset Management business provides investment solutions and investment management services in equity and fixed income strategies, alternative investments and private equity funds to corporations, public funds and sovereign entities.
Company Coordinates stock-summary
Company Details
Clarendon House, 2 Church Street HAMILTON None : HM 11
stock-summary
Tel: 1 441 29514221 212 632 6886
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 71 Schemes (59.22%)

Foreign Institutions

Held by 118 Foreign Institutions (12.1%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Kenneth Jacobs
Chairman of the Board, Chief Executive Officer
Mr. Richard Parsons
Lead Independent Director
Mr. Ashish Bhutani
Vice Chairman of the Board, Managing Director
Mr. Andrew Alper
Independent Director
Dr. Richard Haass
Independent Director
Mr. Steven Heyer
Independent Director
Ms. Michelle Jarrard
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
813 Million
(Quarterly Results - Jun 2025)
Net Profit:
60 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 5,830 Million (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

290.14%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

40.81%

stock-summary
Price to Book

7.86